This is the first of the three-part podcast series, Keeping up with the Chemos on CDK 4/6 inhibitors. After going over some general information on CDK 4/6 inhibitors including when to use the drug, toxicity, response rates, repeat biopsy, and line of therapy and treatment option. The multidisciplinary panel will discuss dosing and drug preparation for giving CDK 4/6 inhibitors. The session wraps up with some key take home points on CDK 4/6 inhibitors.

2024-2025 SGO Chemotherapy and Immunology Subcommittee Lead and Moderator:
Jennifer MacDonald, PharmD, BCOP
 
Speakers: 
Julia Fehniger, MD
Jodi L. Taraba, PharmD, MS, RPh, BCOP
Siddhartha Yadav, M.B.B.S, MD